Review





Similar Products

92
Multi Sciences (Lianke) Biotech Co Ltd human vegf-c elisa kit
Human Vegf C Elisa Kit, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vegf+c/Human+VEGF-C+ELISA+Kit/custom%40ek1154%4042764425
Average 92 stars, based on 1 article reviews
human vegf-c elisa kit - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier

94
MedChemExpress ar tic le in pr es s article
Ar Tic Le In Pr Es S Article, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vegf+c/VEGF-C%2C+Mouse%2FRat/pm42458244-125-0-20
Average 94 stars, based on 1 article reviews
ar tic le in pr es s article - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

94
RayBiotech inc vegf c concentrations
(A) Expression of KDR, encoding VEGFR2, and (B) FLT4, encoding VEGFR3, across publicly available pediatric solid tumor datasets included in the R2 MegaSampler platform. Expression values are presented as log2-transformed signal intensity. The distributions illustrate inter-dataset and inter-tumor heterogeneity in the expression of receptors associated predominantly <t>with</t> <t>VEGF-A</t> <t>and</t> <t>VEGF-C</t> signaling, respectively. M, metastasis; T, primary tumor; ES, Ewing sarcoma; NB, neuroblastoma; OS, osteosarcoma.
Vegf C Concentrations, supplied by RayBiotech inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vegf+c/Human+VEGF-C+ELISA/bio_rxiv__64898__2026__07__25__740695-113-2-12
Average 94 stars, based on 1 article reviews
vegf c concentrations - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

93
MedChemExpress recombinant human vegf a
(A) Expression of KDR, encoding VEGFR2, and (B) FLT4, encoding VEGFR3, across publicly available pediatric solid tumor datasets included in the R2 MegaSampler platform. Expression values are presented as log2-transformed signal intensity. The distributions illustrate inter-dataset and inter-tumor heterogeneity in the expression of receptors associated predominantly <t>with</t> <t>VEGF-A</t> <t>and</t> <t>VEGF-C</t> signaling, respectively. M, metastasis; T, primary tumor; ES, Ewing sarcoma; NB, neuroblastoma; OS, osteosarcoma.
Recombinant Human Vegf A, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vegf+c/VEGF-C%2C+Human/pm42236679-90-0-5
Average 93 stars, based on 1 article reviews
recombinant human vegf a - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

86
Jingmei Biotech Co Ltd relevant parameters vegf c
(A) Expression of KDR, encoding VEGFR2, and (B) FLT4, encoding VEGFR3, across publicly available pediatric solid tumor datasets included in the R2 MegaSampler platform. Expression values are presented as log2-transformed signal intensity. The distributions illustrate inter-dataset and inter-tumor heterogeneity in the expression of receptors associated predominantly <t>with</t> <t>VEGF-A</t> <t>and</t> <t>VEGF-C</t> signaling, respectively. M, metastasis; T, primary tumor; ES, Ewing sarcoma; NB, neuroblastoma; OS, osteosarcoma.
Relevant Parameters Vegf C, supplied by Jingmei Biotech Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vegf+c/commercial+elisa+mouse/pm42156495-112-20-25
Average 86 stars, based on 1 article reviews
relevant parameters vegf c - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

94
MedChemExpress vegfc group
(A) Expression of KDR, encoding VEGFR2, and (B) FLT4, encoding VEGFR3, across publicly available pediatric solid tumor datasets included in the R2 MegaSampler platform. Expression values are presented as log2-transformed signal intensity. The distributions illustrate inter-dataset and inter-tumor heterogeneity in the expression of receptors associated predominantly <t>with</t> <t>VEGF-A</t> <t>and</t> <t>VEGF-C</t> signaling, respectively. M, metastasis; T, primary tumor; ES, Ewing sarcoma; NB, neuroblastoma; OS, osteosarcoma.
Vegfc Group, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vegf+c/VEGF-C%2C+Mouse%2FRat/10__3390_slash_ijms27104297-162-37-39
Average 94 stars, based on 1 article reviews
vegfc group - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

94
MedChemExpress mouse recombinant vegfc
(A) Expression of KDR, encoding VEGFR2, and (B) FLT4, encoding VEGFR3, across publicly available pediatric solid tumor datasets included in the R2 MegaSampler platform. Expression values are presented as log2-transformed signal intensity. The distributions illustrate inter-dataset and inter-tumor heterogeneity in the expression of receptors associated predominantly <t>with</t> <t>VEGF-A</t> <t>and</t> <t>VEGF-C</t> signaling, respectively. M, metastasis; T, primary tumor; ES, Ewing sarcoma; NB, neuroblastoma; OS, osteosarcoma.
Mouse Recombinant Vegfc, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vegf+c/VEGF-C%2C+Mouse%2FRat/pm42044813-65-13-16
Average 94 stars, based on 1 article reviews
mouse recombinant vegfc - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

94
ABclonal Biotechnology vegf c
<t>PAX5</t> suppresses invasion and migration of GAC lymph node metastatic cells. A : CCK-8 assay measuring the viability of GAC lymph node metastatic cells. B and E: Scratch assay demonstrating cell migration; scale bar = 100 μm. C and F: Transwell assay assessing cell invasion; scale bar = 100 μm. D and F : Immunofluorescence analysis of PAX5 expression; scale bar = 50 μm. G : Quantitative PCR (qPCR) analysis of mRNA expression levels of PAX5, <t>VEGF-C,</t> PIK3, and AKT1. H : Western blot analysis of protein expression levels of PAX5, VEGF-C, AKT1, PI3K, MMP2, and Ki-67. “ns” indicates “not significant”; * indicates P < 0.05; ** indicates P < 0.01; *** indicates P < 0.001; **** indicates P < 0.0001
Vegf C, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vegf+c/VEGFC+Rabbit+pAb/pmc13091243-165-10-12
Average 94 stars, based on 1 article reviews
vegf c - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

94
R&D Systems vegfc
<t>PAX5</t> suppresses invasion and migration of GAC lymph node metastatic cells. A : CCK-8 assay measuring the viability of GAC lymph node metastatic cells. B and E: Scratch assay demonstrating cell migration; scale bar = 100 μm. C and F: Transwell assay assessing cell invasion; scale bar = 100 μm. D and F : Immunofluorescence analysis of PAX5 expression; scale bar = 50 μm. G : Quantitative PCR (qPCR) analysis of mRNA expression levels of PAX5, <t>VEGF-C,</t> PIK3, and AKT1. H : Western blot analysis of protein expression levels of PAX5, VEGF-C, AKT1, PI3K, MMP2, and Ki-67. “ns” indicates “not significant”; * indicates P < 0.05; ** indicates P < 0.01; *** indicates P < 0.001; **** indicates P < 0.0001
Vegfc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vegf+c/Recombinant+Human+VEGF-C+(Cys156Ser)+Protein/pm41944190-231-16-17
Average 94 stars, based on 1 article reviews
vegfc - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

Image Search Results


(A) Expression of KDR, encoding VEGFR2, and (B) FLT4, encoding VEGFR3, across publicly available pediatric solid tumor datasets included in the R2 MegaSampler platform. Expression values are presented as log2-transformed signal intensity. The distributions illustrate inter-dataset and inter-tumor heterogeneity in the expression of receptors associated predominantly with VEGF-A and VEGF-C signaling, respectively. M, metastasis; T, primary tumor; ES, Ewing sarcoma; NB, neuroblastoma; OS, osteosarcoma.

Journal: bioRxiv

Article Title: Computationally guided design of a metastasis-on-a-chip platform for quantitative evaluation of chemotactic cues in developmental cancers

doi: 10.64898/2026.07.25.740695

Figure Lengend Snippet: (A) Expression of KDR, encoding VEGFR2, and (B) FLT4, encoding VEGFR3, across publicly available pediatric solid tumor datasets included in the R2 MegaSampler platform. Expression values are presented as log2-transformed signal intensity. The distributions illustrate inter-dataset and inter-tumor heterogeneity in the expression of receptors associated predominantly with VEGF-A and VEGF-C signaling, respectively. M, metastasis; T, primary tumor; ES, Ewing sarcoma; NB, neuroblastoma; OS, osteosarcoma.

Article Snippet: VEGF-A165 and VEGF-C concentrations were quantified using commercially available human ELISA kits (RayBiotech, Peachtree Corners, GA, USA; Catalog Nos.

Techniques: Expressing, Transformation Assay

VEGF-C transport was simulated using initial concentrations of 0.1 or 5 µg/mL in Chamber 2. Predicted VEGF-C concentrations over time are shown in (A) Channel 2, adjacent to the source, (B) at the microchannel array separating Reservoirs 2 and 1, and (C) in Channel 1, on the Chamber 1 side of the device. An initial concentration of 5 µg/mL generated measurable exposure at the microchannel array within the experimental time window, whereas 0.1 µg/mL produced substantially lower concentrations and negligible predicted exposure at the microchannel array and in Channel 1. Different concentration units and y-axis ranges were used for the individual device regions.

Journal: bioRxiv

Article Title: Computationally guided design of a metastasis-on-a-chip platform for quantitative evaluation of chemotactic cues in developmental cancers

doi: 10.64898/2026.07.25.740695

Figure Lengend Snippet: VEGF-C transport was simulated using initial concentrations of 0.1 or 5 µg/mL in Chamber 2. Predicted VEGF-C concentrations over time are shown in (A) Channel 2, adjacent to the source, (B) at the microchannel array separating Reservoirs 2 and 1, and (C) in Channel 1, on the Chamber 1 side of the device. An initial concentration of 5 µg/mL generated measurable exposure at the microchannel array within the experimental time window, whereas 0.1 µg/mL produced substantially lower concentrations and negligible predicted exposure at the microchannel array and in Channel 1. Different concentration units and y-axis ranges were used for the individual device regions.

Article Snippet: VEGF-A165 and VEGF-C concentrations were quantified using commercially available human ELISA kits (RayBiotech, Peachtree Corners, GA, USA; Catalog Nos.

Techniques: Concentration Assay, Generated, Produced

Journal: bioRxiv

Article Title: Computationally guided design of a metastasis-on-a-chip platform for quantitative evaluation of chemotactic cues in developmental cancers

doi: 10.64898/2026.07.25.740695

Figure Lengend Snippet:

Article Snippet: VEGF-A165 and VEGF-C concentrations were quantified using commercially available human ELISA kits (RayBiotech, Peachtree Corners, GA, USA; Catalog Nos.

Techniques: Incubation, Cell Culture, Enzyme-linked Immunosorbent Assay

(A) Representative merged bright-field and fluorescence images of neuroblastoma, Ewing sarcoma, and osteosarcoma cells detected within the microchannel array under control, VEGF-A165, and VEGF-C conditions. Images were processed using a custom Fiji macro that automatically identified the microchannel region, detected fluorescent cells, and retained cells located within the microchannels according to predefined size, circularity, intensity, and channel-overlap criteria. Scale bars =50µm. (B) Quantification of the number of cells detected within the microchannels for neuroblastoma, Ewing sarcoma, and osteosarcoma. Individual data points represent independent microfluidic devices, and bars show mean ± SD. Statistical significance was assessed using ordinary one-way ANOVA followed by Dunnett’s multiple-comparisons test against the corresponding control. *p < 0.05; ns, not significant.

Journal: bioRxiv

Article Title: Computationally guided design of a metastasis-on-a-chip platform for quantitative evaluation of chemotactic cues in developmental cancers

doi: 10.64898/2026.07.25.740695

Figure Lengend Snippet: (A) Representative merged bright-field and fluorescence images of neuroblastoma, Ewing sarcoma, and osteosarcoma cells detected within the microchannel array under control, VEGF-A165, and VEGF-C conditions. Images were processed using a custom Fiji macro that automatically identified the microchannel region, detected fluorescent cells, and retained cells located within the microchannels according to predefined size, circularity, intensity, and channel-overlap criteria. Scale bars =50µm. (B) Quantification of the number of cells detected within the microchannels for neuroblastoma, Ewing sarcoma, and osteosarcoma. Individual data points represent independent microfluidic devices, and bars show mean ± SD. Statistical significance was assessed using ordinary one-way ANOVA followed by Dunnett’s multiple-comparisons test against the corresponding control. *p < 0.05; ns, not significant.

Article Snippet: VEGF-A165 and VEGF-C concentrations were quantified using commercially available human ELISA kits (RayBiotech, Peachtree Corners, GA, USA; Catalog Nos.

Techniques: Fluorescence, Control

PAX5 suppresses invasion and migration of GAC lymph node metastatic cells. A : CCK-8 assay measuring the viability of GAC lymph node metastatic cells. B and E: Scratch assay demonstrating cell migration; scale bar = 100 μm. C and F: Transwell assay assessing cell invasion; scale bar = 100 μm. D and F : Immunofluorescence analysis of PAX5 expression; scale bar = 50 μm. G : Quantitative PCR (qPCR) analysis of mRNA expression levels of PAX5, VEGF-C, PIK3, and AKT1. H : Western blot analysis of protein expression levels of PAX5, VEGF-C, AKT1, PI3K, MMP2, and Ki-67. “ns” indicates “not significant”; * indicates P < 0.05; ** indicates P < 0.01; *** indicates P < 0.001; **** indicates P < 0.0001

Journal: Journal of Translational Medicine

Article Title: Single-cell and spatial transcriptomic analysis reveals PAX5’s role and regulatory mechanisms in gastric adenocarcinoma lymph node metastasis

doi: 10.1186/s12967-026-08059-4

Figure Lengend Snippet: PAX5 suppresses invasion and migration of GAC lymph node metastatic cells. A : CCK-8 assay measuring the viability of GAC lymph node metastatic cells. B and E: Scratch assay demonstrating cell migration; scale bar = 100 μm. C and F: Transwell assay assessing cell invasion; scale bar = 100 μm. D and F : Immunofluorescence analysis of PAX5 expression; scale bar = 50 μm. G : Quantitative PCR (qPCR) analysis of mRNA expression levels of PAX5, VEGF-C, PIK3, and AKT1. H : Western blot analysis of protein expression levels of PAX5, VEGF-C, AKT1, PI3K, MMP2, and Ki-67. “ns” indicates “not significant”; * indicates P < 0.05; ** indicates P < 0.01; *** indicates P < 0.001; **** indicates P < 0.0001

Article Snippet: Antibody details are as follows: PAX5 (A12048, ABclonal, Wuhan, China), VEGF-C (A2556, ABclonal, Wuhan, China), AKT1 (A17909, ABclonal, Wuhan, China), PI3K (A19742, ABclonal, Wuhan, China), MMP2 (A19080, ABclonal, Wuhan, China), and Ki-67 (A16919, ABclonal, Wuhan, China).

Techniques: Migration, CCK-8 Assay, Wound Healing Assay, Transwell Assay, Immunofluorescence, Expressing, Real-time Polymerase Chain Reaction, Western Blot

PAX5 modulates HLEC cell tube formation in a co-culture system. A : Quantification of the number of nodes and total length of major master segments in tube-like structures. B : qPCR analysis of mRNA expression levels of PAX5, VEGF-C, PIK3, and AKT1 in HLEC cells. “ns” indicates “not significant”; * indicates P < 0.05; ** indicates P < 0.01; *** indicates P < 0.001; **** indicates P < 0.0001; scale bars = 100 μm

Journal: Journal of Translational Medicine

Article Title: Single-cell and spatial transcriptomic analysis reveals PAX5’s role and regulatory mechanisms in gastric adenocarcinoma lymph node metastasis

doi: 10.1186/s12967-026-08059-4

Figure Lengend Snippet: PAX5 modulates HLEC cell tube formation in a co-culture system. A : Quantification of the number of nodes and total length of major master segments in tube-like structures. B : qPCR analysis of mRNA expression levels of PAX5, VEGF-C, PIK3, and AKT1 in HLEC cells. “ns” indicates “not significant”; * indicates P < 0.05; ** indicates P < 0.01; *** indicates P < 0.001; **** indicates P < 0.0001; scale bars = 100 μm

Article Snippet: Antibody details are as follows: PAX5 (A12048, ABclonal, Wuhan, China), VEGF-C (A2556, ABclonal, Wuhan, China), AKT1 (A17909, ABclonal, Wuhan, China), PI3K (A19742, ABclonal, Wuhan, China), MMP2 (A19080, ABclonal, Wuhan, China), and Ki-67 (A16919, ABclonal, Wuhan, China).

Techniques: Co-Culture Assay, Expressing

In vivo validation of PAX5 functional mechanisms. A : Hematoxylin and eosin (H&E) staining of mouse tumors. B : Immunohistochemical analysis of PAX5, Ki-67, and MMP2 expression in mouse tumors. C : qPCR analysis of mRNA expression levels of PAX5, PIK3, AKT1, and VEGF-C in mouse tumors. D : Western blot analysis of protein expression levels of PAX5, PI3K, AKT1, and VEGF-C in mouse tumors. * indicates P < 0.05; ** indicates P < 0.01; *** indicates P < 0.001; **** indicates P < 0.0001; scale bars = 50 μm

Journal: Journal of Translational Medicine

Article Title: Single-cell and spatial transcriptomic analysis reveals PAX5’s role and regulatory mechanisms in gastric adenocarcinoma lymph node metastasis

doi: 10.1186/s12967-026-08059-4

Figure Lengend Snippet: In vivo validation of PAX5 functional mechanisms. A : Hematoxylin and eosin (H&E) staining of mouse tumors. B : Immunohistochemical analysis of PAX5, Ki-67, and MMP2 expression in mouse tumors. C : qPCR analysis of mRNA expression levels of PAX5, PIK3, AKT1, and VEGF-C in mouse tumors. D : Western blot analysis of protein expression levels of PAX5, PI3K, AKT1, and VEGF-C in mouse tumors. * indicates P < 0.05; ** indicates P < 0.01; *** indicates P < 0.001; **** indicates P < 0.0001; scale bars = 50 μm

Article Snippet: Antibody details are as follows: PAX5 (A12048, ABclonal, Wuhan, China), VEGF-C (A2556, ABclonal, Wuhan, China), AKT1 (A17909, ABclonal, Wuhan, China), PI3K (A19742, ABclonal, Wuhan, China), MMP2 (A19080, ABclonal, Wuhan, China), and Ki-67 (A16919, ABclonal, Wuhan, China).

Techniques: In Vivo, Biomarker Discovery, Functional Assay, Staining, Immunohistochemical staining, Expressing, Western Blot